Incidence of trastuzumab‑induced cardiotoxicity and impact of body mass index in patients with breast cancer: Results from a Saudi tertiary cancer center-Reference-Cited by-同舟云学术

Incidence of trastuzumab‑induced cardiotoxicity and impact of body mass index in patients with breast cancer: Results from a Saudi tertiary cancer center

Published:2022-02-08 Issue:4 Volume:16 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Al‑Saleh Khalid¹,Abdel‑Warith Ahmed²,Alghamdi Mohammed²,Aldiab Abdurrahman²,Ali Arwa³,Alsaeed Eyad⁴,Abozeed Waleed⁵,Abdel‑aziz Nashwa²

Affiliation:

1. Department of Medicine, College of Medicine, King Saud University, Riyadh 12372, Saudi Arabia

2. Division of Hematology/Oncology, Department of Medicine, King Khalid University Hospital, College of Medicine, King Saud University Medical City, Riyadh 12372, Saudi Arabia

3. Department of Medical Oncology, South Egypt Cancer Institute, Assiut University, Assiut 71516, Egypt

4. Department of Oncology, Division of Radiation Oncology, King Khalid University Hospital, College of Medicine, King Saud University Medical City, Riyadh 12372, Saudi Arabia

5. Clinical Oncology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference41 articles.

1. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: A meta-analysis;Cheraghi;PLoS One,2012

2. Obesity as a risk factor for development and poor prognosis of breast cancer;Carmichael;BJOG,2006

3. Obesity and breast cancer: A review of the literature;Carmichael;Breast,2004

4. The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: The experience of the BIG 02-98 trial;De Azambuja;Breast Cancer Res Treat,2010

5. Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer;Guenancia;Arch Cardiovasc Dis,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in Epicardial Adipose Tissue Assessed by Chest CT in Breast Cancer Patients Receiving Adjuvant Chemotherapy with Anthracyclines and Trastuzumab;Reviews in Cardiovascular Medicine;2024-07-09

2. GDF-15 is a potential candidate biomarker for an elevated risk of cardiotoxicity in breast cancer patients receiving neoadjuvant dual anti-HER2 therapy;Frontiers in Pharmacology;2024-05-17

3. Assessing Adherence to Cardiac Monitoring Guidelines in Trastuzumab-Treated Breast Cancer Patients: Insights From a Tertiary Hospital;Cureus;2023-11-15